510(k) K242190
K242190 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "Access Cortisol; DxC 500i Clinical Analyzer". The FDA issued a decision of Substantially Equivalent on March 5, 2025. The device falls under product code CGR (Radioimmunoassay, Cortisol), a Class II device regulated under 21 CFR 862.1205. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 5, 2025
- Date Received
- July 25, 2024
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Cortisol
- Device Class
- Class II
- Regulation Number
- 862.1205
- Review Panel
- CH
- Submission Type